Third Military Medical University - Army Medical University Reports Findings in Lung Cancer (Integrated multi-omics and machine learning reveal a gefitinib resi stance signature for prognosis and treatment response in lung adenocarcinoma)

Robotics & Machine Learning Daily News2024，Issue(Dec.13) ：114-115.

来源：

NETL
NSTL

Third Military Medical University - Army Medical University Reports Findings in Lung Cancer (Integrated multi-omics and machine learning reveal a gefitinib resi stance signature for prognosis and treatment response in lung adenocarcinoma)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Lung Cancer is the subject of a report. According to newsoriginating from Chongqing, Peopl e’s Republic of China, by NewsRx correspondents, research stated,“Gefitinib res istance (GR) presents a significant challenge in treating lung adenocarcinoma (L UAD),highlighting the need for alternative therapies. This study explores the g enetic basis of GR to improveprediction, prevention, and treatment strategies.”

Key words

Chongqing/People’s Republic of China/A sia/Adenocarcinoma/Antineoplastics/Cancer/Cyborgs/Drugs and Therapies/EGFR Inhibitors/Emerging Technologies/Gefitinib Therapy/Genetics/Health and Medi cine/Immunotherapy/Lung Cancer/Lung Diseases and Conditions/Machine Learning/Oncology/Pharmaceuticals/Tyrosine Kinase Inhibitors

引用本文复制引用

出版年

2024

Robotics & Machine Learning Daily News

ISSN：

段落导航